mRNA 합성 원료 시장 규모, 점유율 및 성장 분석 : 원료 유형별, 수식 뉴클레오티드별, 용도별, 최종사용자별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global mRNA Synthesis Raw Materials Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.89 Billion in 2025 to USD 8.85 Billion by 2033, growing at a CAGR of 14.82% during the forecast period (2026-2033).

The market for mRNA synthesis raw materials is being propelled by the surging demand for mRNA vaccines and therapeutics, alongside heightened investment in biotechnology research and a broadened clinical pipeline for related products. The transition of mRNA candidates from research to clinical stages demands increased technological advancements in biomanufacturing and a strong emphasis on personalized medicine. Furthermore, the rise in demand for GMP-grade materials suitable for large-scale production is pushing biotechnology firms to seek regulatory-compliant raw materials. This has led to expanded production capacities for essential components, alleviating supply bottlenecks and enhancing manufacturing efficiency. However, challenges such as high production costs, strict regulations, and supply chain limitations may hinder market growth despite the promising potential of next-gen vaccines and therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global mRNA Synthesis Raw Materials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global mRNA Synthesis Raw Materials Market Segments Analysis

Global mRNA synthesis raw materials market is segmented by raw material type, application, end-user, distribution channel, and region. Based on raw material type, the market is segmented into Nucleoside Triphosphates (NTPs), Modified Nucleosides (m1Ψ, pseudouridine), Cap Analogs (ARCA, CleanCap), Poly-A Tailing Reagents, and Plasmid DNA Templates. Based on application, the market is segmented into vaccine manufacturing, therapeutics, and research. Based on end-user, the market is segmented into mRNA vaccine manufacturers, pharma & biotech companies, and CDMOs. Based on distribution channel, the market is segmented into direct B2B and distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global mRNA Synthesis Raw Materials Market

The increasing demand for mRNA-based drugs and therapies is significantly driving the need for raw materials as biopharmaceutical companies enhance their development pipelines and seek wider applications. This surge in demand for high-quality nucleotides, enzymes, and specialized reagents is prompting manufacturers to transition from concept to clinical trials and ultimately to market release. Consequently, suppliers are encouraged to scale operations and innovate solutions for these essential raw materials. The continuous growth in this sector will attract investment in value chains and foster a supply network that supports expanding supplier capabilities, thereby facilitating new mRNA applications and enhancing market accessibility.

Restraints in the Global mRNA Synthesis Raw Materials Market

The Global mRNA Synthesis Raw Materials market faces significant constraints due to the inherent complexity of its supply chain, which impacts market size and penetration. A limited number of suppliers provide key niche inputs, creating vulnerabilities in availability and stability. The transportation of temperature-sensitive materials further complicates logistics, leading to potential delays and quality issues that encourage conservative inventory practices. This uncertainty in securing essential materials hampers rapid scaling of manufacturing processes, establishing higher barriers for new entrants and innovative formulations. Consequently, buyers tend to favor established, reliable suppliers, resulting in slower adoption of emerging manufacturers and novel products in the market.

Market Trends of the Global mRNA Synthesis Raw Materials Market

The Global mRNA Synthesis Raw Materials market is experiencing a significant trend driven by therapeutic platform diversification. Expanding applications of mRNA technology, particularly in oncology, rare diseases, and regenerative medicine, are generating a heightened demand for an expanded range of high-quality raw materials. Consequently, reagent suppliers are now providing specialized nucleotides, modified cap structures, and unique excipients designed to meet specific therapeutic needs. This evolution is prompting enhanced collaboration between reagent manufacturers and biotechnology firms to establish custom specifications for these materials, underscoring the importance of tailored solutions in meeting the diverse requirements of the mRNA synthesis market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global mRNA Synthesis Raw Materials Market Size by Raw Material Type & CAGR (2026-2033)

• Market Overview
• Nucleoside Triphosphates (NTPs)
• Modified Nucleosides (m1Ψ, pseudouridine)
• Cap Analogs (ARCA, CleanCap)
• Poly-A Tailing Reagents
• Plasmid DNA Templates

Global mRNA Synthesis Raw Materials Market Size by Application & CAGR (2026-2033)

• Market Overview
• Vaccine Manufacturing
• Therapeutics
• Research

Global mRNA Synthesis Raw Materials Market Size by End-User & CAGR (2026-2033)

• Market Overview
• mRNA Vaccine Manufacturers
• Pharma & Biotech Companies
• CDMOs

Global mRNA Synthesis Raw Materials Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Direct B2B
• Distributors

Global mRNA Synthesis Raw Materials Market Size & CAGR (2026-2033)

• North America (Raw Material Type, Application, End-User, Distribution)
  • US
  • Canada
• Europe (Raw Material Type, Application, End-User, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Raw Material Type, Application, End-User, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Raw Material Type, Application, End-User, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Raw Material Type, Application, End-User, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (MilliporeSigma)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trilink Biotechnologies (Maravai)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jena Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hongene Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arctus Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codex DNA (Twist Bioscience)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aldevron (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PNABio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CureVac AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Bio-Pharma Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recombinant Technology Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMimetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations